Lisata Therapeutics Inc.

NASDAQ: LSTA · Real-Time Price · USD
2.52
-0.04 (-1.56%)
At close: Aug 15, 2025, 3:59 PM
2.53
0.40%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lisata Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
70K n/a 1M n/a n/a n/a n/a n/a n/a n/a 121.37M n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
44K 43K n/a 41K 45K 46K 47K 47K 48K 48K 47K 8K 7K 7K 8K 14K 17K 16K
Gross Profit
26K -43K 1M -41K -45K -46K -47K -47K -48K -48K 121.33M -8K -7K -7K -8K -14K -17K -16K
Operating Income
-4.87M -5.85M -4.95M -5.34M -5.52M -6.6M -6.03M -5.96M -6.88M -6.84M -6.54M -7.33M -6.72M -6.62M -6.85M -6.97M -7.15M -8.09M
Interest Income
216K 266K 350K 451K 493K 589K 671K 714K 668K n/a 556K n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-4.66M -5.69M -4.61M -4.93M -5.04M -6.2M -5.37M -5.26M -6.36M -6.19M -5.99M -37.38M -6.63M -6.71M -6.79M -6.93M -7.19M -8.06M
Net Income
-4.66M -4.72M -4.61M -4.93M -5.04M -5.4M -5.37M -5.26M -4.03M -6.19M -5.99M -37.38M -6.44M -4.23M -6.79M -6.93M -5.68M -8.06M
Selling & General & Admin
2.69M 3.25M 3M 2.79M 2.92M 3.31M 3.01M 2.58M 3.71M 3.67M 3.37M 3.95M 3.48M 3.34M 2.7M 2.84M 2.82M 3.01M
Research & Development
2.25M 2.6M 2.95M 2.54M 2.6M 3.24M 3.01M 3.38M 3.16M 3.18M 3.17M 33.77M 3.24M 3.28M 4.15M 4.13M 4.33M 5.08M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a -13K -6K n/a n/a n/a 15K n/a n/a n/a
Operating Expenses
4.94M 5.85M 5.95M 5.34M 5.52M 6.55M 6.03M 5.96M 6.88M 6.84M 6.54M 37.72M 6.72M 6.62M 6.85M 6.97M 7.15M 8.09M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.37M n/a n/a 22K n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -46K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
4.94M 5.85M 5.95M 5.34M 5.52M 6.6M 6.03M 5.96M 6.88M 6.84M 6.54M 37.72M 6.72M 6.62M 6.85M 6.97M 7.15M 8.09M
Income Tax Expense
n/a -962K n/a n/a n/a -798K n/a n/a -2.33M n/a n/a -674K -188K -2.48M -40K n/a -1.51M -46K
Shares Outstanding (Basic)
8.61M 8.6M 8.33M 8.32M 8.31M 8.29M 8.14M 8.14M 8.02M 7.99M 4.96M 4.75M 4.04M 4.04M 3.98M 3.97M 3.97M 2.81M
Shares Outstanding (Diluted)
8.61M 8.6M 8.33M 8.32M 8.31M 8.29M 8.14M 8.14M 8.02M 7.99M 4.96M 4.75M 4.04M 4.04M 3.98M 3.97M 3.97M 2.81M
EPS (Basic)
-0.54 -0.55 -0.55 -0.59 -0.61 -0.65 -0.66 -0.65 -0.5 -0.77 -1.21 -7.88 -1.6 -1.05 -1.7 -1.74 -1.43 -2.87
EPS (Diluted)
-0.54 -0.55 -0.55 -0.59 -0.61 -0.65 -0.66 -0.65 -0.5 -0.77 -1.21 -7.88 -1.6 -1.05 -1.7 -1.74 -1.43 -2.87
EBITDA
-4.62M -5.64M -4.57M -5.29M -5.48M -6.55M -5.98M -5.92M -6.83M -6.8M -6.49M -37.38M -6.71M -6.61M -6.84M -6.95M -7.13M -8.07M
EBIT
-4.66M -5.69M -4.95M -5.34M -5.52M -6.6M -6.03M -5.96M -6.88M -6.84M -6.54M -37.38M -6.72M -6.62M -6.85M -6.97M -7.15M -8.09M
Depreciation & Amortization
44K 43K 41K 42K 45K 46K 47K 47K 47K 48K 47K 8K 7K 7K 8K 14K 17K 16K